Amyloidosis - 258 Studies Found Completed : Phase 1 Study of GSK2315698 in Healthy Japanese Subjects : Amyloidosis : 2016-11-01 : Drug: Placebo 0.9% weight by v Completed : Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction : Amyloid-beta : 2014-01-29 : Drug: Sodium Oxybate Sodium ox Active, not recruiting : Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging : Amyloidosis Paraproteinemias : 2015-06-01 : Other: Amyloidosis Patients wi Completed : Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis : Amyloidosis : 2015-01-12 : Other: Immunohistochemistry Other: Proteom Completed : SAP Depleter Dose Escalation Study in Healthy Volunteers : Amyloidosis : 2011-03-24 : Drug: GSK2315698 5mg-400mg IV Completed : A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers : TTR-mediated Amyloidosis : 2013-03-18 : Drug: ALN-TTRSC (revusiran) As Completed : Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects : TTR-mediated Amyloidosis : 2012-03-19 : Drug: ALN-TTR02 Dose levels be Completed : A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers : Transthyretin (TTR)-Mediated Amyloidosis : 2014-01-24 : Drug: patisiran (ALN-TTR02) As Completed : The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant : Transthyretin (TTR)-Mediated Amyloidosis Familial Amyloidotic P : 2015-10-30 : Drug: Revusiran (ALN-TTRSC) 500mg Revusiran by subcutaneous (sc) injection Completed : Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant : Cardiomyopathy : 2007-04-02 <<< Previous | Next >>>
